Amount of gain recognized in the period that had been disclosed in prior periods as a contingent gain.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 17

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Name:	us-gaap_FormerGainContingencyRecognizedInCurrentPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Litigation (Details) (USD $) In Millions, unless otherwise specified		0 Months Ended		12 Months Ended
	Sep. 30, 2012	Sep. 24, 2012 Lexington Insurance Company	Sep. 30, 2011 Lexington Insurance Company	Dec. 31, 2012 Sandoz Inc
Litigation
Maximum period for which the FDA is automatically precluded from approving Sandoz's ANDA				30 months
Estimated net commercial value of damaged inventory			$ 65.0
Settlement agreement	$ 31.0	$ 31.0
Period from the date of execution in which settlement agreement amount will be paid		30 days